400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Neuronal Signaling / AMPAR & Kainate receptor / Selurampanel
CAS No.: 912574-69-7
Synonyms: BGG 492
Selurampanel is a competitive AMPA/kainate receptor antagonist drug for epilepsy.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00892203 | Migraine | Phase 2 | Completed | - | United States, California ... more >> California Clinical Trials, 1560 Chevy Chase Drive, Suite 140 Glendale, California, United States, 91206 California Clinical Trials, 15625 Lakewood Boulevard Paramount, California, United States, 90723 Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Essen, Germany Novartis Investigative Site Goettingen, Germany Novartis Investigator Site Hamburg, Germany Novartis Investigative Site Kiel, Germany Novartis Investigative Site Koenigstein, Germany Novartis Investigative Site Muenster, Germany Novartis Investigative Site Munich, Germany Novartis Investigator Site Munich, Germany Novartis Investigative Site Wurzburg, Germany Spain Novartis Investigative Site Barcelona, Spain Collapse << |
NCT00784212 | Photosensitive Epilepsy | Phase 2 | Completed | - | Germany ... more >> Novartis Investigator Site Bielefeld, Germany Novartis Investigator Site Kehl-Kork, Germany Novartis Investigator Site Kiel, Germany Novartis Investigator Site Radeberg, Germany Collapse << |
NCT01302873 | Chronic Subjective Tinnitus | Phase 2 | Completed | - | Germany ... more >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Frankfurt, Germany Novartis Investigative Site Lepzig, Germany Netherlands Novartis Investigative Site Groningen, Netherlands, 9700 Collapse << |
实验方案
技术信息
CAS号 | 912574-69-7 | 储存条件 |
|
|
分子式 | C16H19N5O4S | 运输 | 蓝冰 | |
分子量 | 377.42 | 别名 | BGG 492 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00892203 | Migraine | Phase 2 | Completed | - | United States, California ... more >> California Clinical Trials, 1560 Chevy Chase Drive, Suite 140 Glendale, California, United States, 91206 California Clinical Trials, 15625 Lakewood Boulevard Paramount, California, United States, 90723 Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Essen, Germany Novartis Investigative Site Goettingen, Germany Novartis Investigator Site Hamburg, Germany Novartis Investigative Site Kiel, Germany Novartis Investigative Site Koenigstein, Germany Novartis Investigative Site Muenster, Germany Novartis Investigative Site Munich, Germany Novartis Investigator Site Munich, Germany Novartis Investigative Site Wurzburg, Germany Spain Novartis Investigative Site Barcelona, Spain Collapse << |
NCT00784212 | Photosensitive Epilepsy | Phase 2 | Completed | - | Germany ... more >> Novartis Investigator Site Bielefeld, Germany Novartis Investigator Site Kehl-Kork, Germany Novartis Investigator Site Kiel, Germany Novartis Investigator Site Radeberg, Germany Collapse << |
NCT01302873 | Chronic Subjective Tinnitus | Phase 2 | Completed | - | Germany ... more >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Frankfurt, Germany Novartis Investigative Site Lepzig, Germany Netherlands Novartis Investigative Site Groningen, Netherlands, 9700 Collapse << |
NCT00887861 | Seizures Epil... more >>epsy Collapse << | Phase 2 | Completed | - | Germany ... more >> Novartis Investigator Site Berlin, Germany Novartis Investigator Site Bielefeld, Germany Novartis Investigator Site Bonn, Germany Novartis Investigator Site Erlangen, Germany Novartis Investigator Site Freiburg, Germany Novartis Investigator Site Munich, Germany Collapse << |
NCT01649050 | Muscle Spasticity Due to Multi... more >>ple Sclerosis Collapse << | Phase 2 | Withdrawn | March 2018 | - |
NCT01617941 | Patients With Migraine Equal o... more >>f /More Than 3 and Equal of/ Less Than 12 Migraine Attacks/4 Weeks for Each of the Last 6 Months Preceding the Screening Collapse << | Phase 2 | Withdrawn | November 2016 | - |
NCT02150213 | - | - | Completed | - | - |
NCT01147003 | Partial Onset Seizures | Phase 2 | Completed | - | - |
NCT01338805 | Partial Onset Seizures | Phase 2 | Completed | - | United States, Florida ... more >> Novartis Investigative Site Tallahassee, Florida, United States, 32308 United States, New Jersey Novartis Investigative Site Hamilton, New Jersey, United States, 08619 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75230 Germany Novartis Investigative Site Bernau, Germany, 16321 Novartis Investigative Site Bielefeld, Germany, 33617 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Kehl-Kork, Germany, 77694 Novartis Investigative Site Ulm, Germany, 89081 Hungary Novartis Investigative Site Budapest, Hungary, 1096 Novartis Investigative Site Kecskemet, Hungary, 6000 Novartis Investigative Site Szombathely, Hungary, 9700 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 135-710 Poland Novartis Investigative Site Warsaw, Poland, 02-957 Slovakia Novartis Investigative Site Banska Bystrica, Slovakia, 97517 Novartis Investigative Site Kosice, Slovakia, 041 90 Collapse << |
NCT02150213 | Adrenocortical Adenoma ... more >> Endometrial Stromal Sarcomas Collapse << | Phase 2 | Completed | - | United States, Florida ... more >> Novartis Investigative Site Tallahassee, Florida, United States, 32308 United States, Maryland Novartis Investigative Site Baltimore, Maryland, United States, 21287 United States, New Jersey Novartis Investigative Site Monroe Township, New Jersey, United States, 08831 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75230 Germany Novartis Investigative Site Bernau, Germany, 16321 Novartis Investigative Site Bielefeld, Germany, 33617 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Kehl-Kork, Germany, 77694 Novartis Investigative Site Ulm, Germany, 89081 Hungary Novartis Investigative Site Budapest, Hungary, H-1097 Novartis Investigative Site Kecskemet, Hungary, 6000 Novartis Investigative Site Szombathely, Hungary, 9700 Italy Novartis Investigative Site Firenze, FI, Italy, 50143 Novartis Investigative Site Milano, MI, Italy, 20142 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Slovakia Novartis Investigative Site Hlohovec, Slovak Republic, Slovakia, 92001 Novartis Investigative Site Kosice, Slovak Republic, Slovakia, 041 90 Novartis Investigative Site Banska Bystrica, Slovakia, 97517 Collapse << |
NCT01167335 | Partial Onset Seizures | Phase 2 | Withdrawn | - | United States, Alabama ... more >> University of South Alabama Mobile, Alabama, United States, 36693 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Wisconsin Epilepsy Care Specialists, S.C. Milwaukee, Wisconsin, United States, 53215 Austria Novartis Investigative Site Salzburg, Austria, A-5020 Novartis Investigative Site Vienna, Austria, 1090 Novartis Investigational Site Wien, Austria, 1130 Belgium Novartis Investigative Site Duffel, Belgium, 2570 Novartis Investigative Site Ottignies, Belgium, 1340 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1113 Canada, Quebec Novartis Investigative Site Greenfield Park, Quebec, Canada, J4V 2J2 Novartis Investigative Site Montreal, Quebec, Canada, H2L 4M1 Estonia Novartis Investigative Site Tallinn, Estonia, 10617 Novartis Investigative Site Tartu, Estonia, 51014 India Novartis Investigative Site Bangalore, Karnataka, India, 560054 Novartis Investigative Site Mumbai, Maharashtra, India, 400012 Novartis Investigative Site Dehli, New Delhi, India, 110002 Novartis Investigative Site Jaipur, India, 302004 Latvia Novartis Investigative Site Riga, Latvia, 1002 Novartis Investigative Site Riga, Latvia, LV-1038 Lithuania Novartis Investigative Site Kaunas, Lithuania, 50009 Romania Novartis Investigative Site Bucharest, Romania, 011635 Novartis Investigative Site Bucharest, Romania, 024092 Spain Novartis Investigative Site Barcelona, Spain, 08036 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网